SANA Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

03

Prezzo $2.89

Capitalizzazione di Mercato (MRQ) $865M

P/E -3.0

EPS $-0.96

ROE -172.3%

Intervallo 52 sett. $3–$7

SANA Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

04

intervallo

barre

La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.

Informazioni su Sana Biotechnology, Inc. - Common Stock Panoramica della società da Wikipedia

05 · wikidata

Wikidata ↗

settoreHealthcare industriaBiotechnology dipendenti142 paeseUS

Performance decennale Andamento di ricavi, utile netto, margini e EPS

06

EPS$-0.96

2020-12-31 → 2025-12-31

Flusso di cassa libero$-145M

2021-12-31 → 2025-12-31

Valutazione e Rapporti 07–12

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica	SANA	media 5 anni	Mediana dei peer	Verdetto
P/E	-3.0media 5 anni ≈-3.7	≈-3.7	·	·
P/B (MRQ)	5.6media 5 anni ≈3.3	≈3.3	4.7	Sopravvalutato
Prezzo / FCF (TTM)	-6.4media 5 anni ≈-4.9	≈-4.9	·	·
Prezzo / Flusso di cassa (TTM)	-6.5media 5 anni ≈-5.3	≈-5.3	·	·
Prezzo / Valore contabile tangibile (MRQ)	9.1media 5 anni ≈6.1	≈6.1	·	·

La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica	Tendenza 5 anni	SANA	media 5 anni	Mediana dei peer	Verdetto
ROA		-53.2%media 5 anni ≈-42.0%	≈-42.0%	-35.0%	Debole
ROE		-172.3%media 5 anni ≈-90.7%	≈-90.7%	-50.7%	Debole

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica	Tendenza 5 anni	SANA	media 5 anni	Mediana dei peer	Verdetto
Rapporto corrente (MRQ)		1.4media 5 anni ≈3.7	≈3.7	6.4	Bassa liquidità
Quick Ratio		1.8media 5 anni ≈3.5	≈3.5	4.6	Bassa liquidità

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica	SANA	media 5 anni	Mediana dei peer	Verdetto
EPS (Diluted) (EPS (Diluito))	$-0.96media 5 anni ≈$-1.43	≈$-1.43	·	·
Cash Flow / Share (Flusso di cassa / Azione)	$-0.57media 5 anni ≈$-1.09	≈$-1.09	·	·
Cash / Share (Liquidità / Azione)	$0.27media 5 anni ≈$0.76	≈$0.76	·	·

valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

14

Sorpresa media -12.9%

Prossimo report Nov 04, 2026

Periodo	Rapporto	EPS Actual	EPS Stimato	Sorpresa
30 Giugno 2026	Ago 10, 2026	$-0.22	$-0.15	-47.9%
31 Marzo 2026	Mag 13, 2026	$-0.17	$-0.17	1.7%
31 Dicembre 2025		$-0.21	$-0.14	-55.0%
30 Settembre 2025		$-0.16	$-0.18	12.8%
30 Giugno 2025		$-0.21	$-0.21	0.47%
31 Marzo 2025		$-0.21	$-0.23	10.3%

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

15

Conto Economico 13

Metrica	2025	2024	2023	2022	2021	2020
R&D Expense	$132M	$216M	$262M	$286M	$249M	$133M
SG&A Expense	$44M	$64M	$73M	$72M	$50M	$28M
Operating Expenses	$250M	$273M	$293M	$273M	$357M	$286M
Operating Income	$-250M	$-273M	$-293M	$-273M	$-357M	$-286M
Other Non-op	$2M	$-5M	$-52.0K	$-674.0K	$305.0K	$97.0K
Pretax Income	·	·	·	·	$-356M	$-285M
Income Tax	$0	·	·	·	·	·
Net Income	$-244M	$-267M	$-283M	$-269M	$-356M	$-285M
EPS (Basic)	$-0.96	$-1.16	$-1.46	$-1.43	$-2.14	$-21.92
EPS (Diluted)	$-0.96	$-1.16	$-1.46	$-1.43	$-2.14	$-21.92
Shares (Basic)	253,234,000	230,891,000	194,541,000	188,344,000	166,433,000	13,014,000
Shares (Diluted)	253,234,000	230,891,000	194,541,000	188,344,000	166,433,000	13,014,000
EBITDA	$-250M	$-273M	$-293M	$-273M	$-357M	·

Stato Patrimoniale 23

Metrica	2025	2024	2023	2022	2021	2020
Cash & Equivalents	$72M	$128M	$134M	$177M	$253M	$125M
Short-term Investments	$67M	$25M	$72M	$247M	$298M	$253M
Prepaid Expense	$6M	$4M	$4M	$14M	$7M	$6M
Current Assets	$149M	$161M	$214M	$444M	$558M	$384M
PP&E (Net)	$27M	$77M	$71M	$67M	$65M	$47M
PP&E (Gross)	$82M	$131M	$112M	$101M	$84M	$55M
Accum. Depreciation	$55M	$54M	$42M	$34M	$19M	$8M
Goodwill	$141M	$141M	$141M	$141M	$141M	$141M
Intangibles	$59M	$59M	$59M	$59M	$59M	$59M
Other Non-current Assets	$3M	$5M	$6M	$5M	$5M	$190.0K
Total Assets	$417M	$501M	$565M	$823M	$1.13B	$730M
Accounts Payable	$2M	$5M	$4M	$3M	$2M	$2M
Current Liabilities	$79M	$45M	$64M	$112M	$99M	$31M
Capital Leases	$64M	$82M	$91M	$96M	$102M	$68M
Other Non-current Liabilities	$11M	$10M	·	·	·	$540.0K
Total Liabilities	$256M	$251M	$278M	$323M	$401M	$299M
Common Stock	$27.0K	$22.0K	$20.0K	$19.0K	$18.0K	$2.0K
Paid-in Capital	$2.01B	$1.86B	$1.63B	$1.56B	$1.52B	$8M
Retained Earnings	$-1.85B	$-1.60B	$-1.34B	$-1.05B	$-785M	$-429M
AOCI	$28.0K	$14.0K	$-60.0K	$-4M	$-1M	$30.0K
Stockholders' Equity	$161M	$251M	$288M	$499M	$729M	$-421M
Liabilities + Equity	$417M	$501M	$565M	$823M	$1.13B	$730M
Shares Outstanding	266,732,000	223,923,000	197,857,000	191,022,000	184,929,000	16,170,000

Flusso di cassa 10

Metrica	2025	2024	2023	2022	2021	2020
Stock-based Comp	$25M	$38M	$36M	$38M	$22M	$6M
Amort. of Intangibles	$0	$0	$0	$0	$0	·
Operating Cash Flow	$-144M	$-223M	$-254M	$-290M	$-251M	$-138M
CapEx	$938.0K	$33M	$20M	$21M	$30M	$24M
Investing Cash Flow	$-40M	$17M	$172M	$211M	$-246M	$-253M
Stock Issued	$126M	$181M	$27M	$4M	$5M	·
Net Stock Activity	$126M	·	$5M	$601.0K	·	·
Financing Cash Flow	$129M	$200M	$32M	$5M	$632M	$436M
Net Change in Cash	$-55M	$-6M	$-50M	$-75M	$135M	$45M
Free Cash Flow	$-145M	$-257M	$-274M	$-311M	$-281M	·

Redditività 2

Metrica	Tendenza	2025	2024	2023	2022	2021	2020
ROA		-53.2%	-50.0%	-40.8%	-27.6%	-38.3%	·
ROE		-172.3%	-98.3%	-86.7%	-50.6%	-45.7%	·

Liquidità e Solvibilità 2

Metrica	Tendenza	2025	2024	2023	2022	2021	2020
Current Ratio		1.9	3.5	3.3	4.0	5.6	·
Quick Ratio		1.8	3.4	3.2	3.8	5.6	·

Per Azione 4

Metrica	2025	2024	2023	2022	2021	2020
Book Value / Share	$0.60	$1.12	$1.45	$2.61	$3.94	·
Cash Flow / Share	$-0.57	$-0.97	$-1.30	$-1.54	·	·
Cash / Share	$0.27	$0.57	$0.67	$0.93	$1.37	·
EPS (TTM)	$-0.96	$-1.16	$-1.46	$-1.43	$-2.14	$-21.92

Valutazione (TTM) 8

Metrica	2025	2024	2023	2022	2021	2020
Net Income TTM	$-244M	$-267M	$-283M	$-269M	$-356M	$-285M
Market Cap	$1.09B	$365M	$807M	$755M	$2.86B	·
P/E	-4.2	-1.4	-2.8	-2.8	-7.2	·
P/B	6.7	1.5	2.8	1.5	3.9	·
P / Tangible Book	·	7.2	9.2	2.5	5.4	·
P / Cash Flow	-7.5	-1.6	-3.2	-2.6	-11.4	·
P / FCF	-7.5	-1.4	-3.0	-2.4	-10.2	·
Earnings Yield	-23.6%	-71.2%	-35.8%	-36.2%	-13.8%	·

Conto Economico 11

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
R&D Expense	$31M	$29M	$35M	$30M	$30M	$37M	$45M	$53M	$61M	$56M	$66M	$73M	$67M	$77M	$73M	$73M
SG&A Expense	$11M	$11M	$12M	$10M	$10M	$11M	$17M	$14M	$16M	$16M	$19M	$17M	$17M	$16M	$18M	$14M
Operating Expenses	$65M	$49M	$61M	$44M	$95M	$51M	$51M	$62M	$49M	$111M	$2M	$116M	$84M	$86M	$73M	$32M
Operating Income	$-65M	$-49M	$-61M	$-44M	$-95M	$-51M	$-51M	$-62M	$-49M	$-111M	$-2M	$-116M	$-84M	$-86M	$-73M	$-32M
Other Non-op	$656.0K	$453.0K	$1M	$360.0K	$598.0K	$249.0K	$141.0K	$-742.0K	$-4M	$215.0K	$303.0K	$-84.0K	$-47.0K	$-106.0K	$-198.0K	$-102.0K
Net Income	$-64M	$-47M	$-59M	$-42M	$-94M	$-49M	$-49M	$-60M	$-50M	$-107M	$984.0K	$-114M	$-82M	$-85M	$-72M	$-31M
EPS (Basic)	$-0.22	$-0.17	$-0.20	$-0.16	$-0.39	$-0.21	$-0.21	$-0.25	$-0.21	$-0.49	$0.00	$-0.59	$-0.43	$-0.45	$-0.39	$-0.17
EPS (Diluted)	$-0.22	$-0.17	$-0.20	$-0.16	$-0.39	$-0.21	$-0.21	$-0.25	$-0.21	$-0.49	$0.00	$-0.59	$-0.43	$-0.45	$-0.39	$-0.17
Shares (Basic)	295,667,000	276,856,000	·	260,494,000	238,409,000	237,578,000	·	235,412,000	234,440,000	217,290,000	196,978,000	192,540,000	191,228,000	189,303,000	187,626,000	185,955,000
Shares (Diluted)	295,667,000	276,856,000	·	260,494,000	238,409,000	237,578,000	·	235,412,000	234,440,000	217,290,000	200,473,000	192,540,000	191,228,000	189,303,000	187,626,000	185,955,000
EBITDA	·	$-49M	·	$-44M	$-95M	$-51M	·	$-62M	$-49M	$-111M	$-2M	$-116M	$-84M	$-86M	$-73M	$-32M

Stato Patrimoniale 23

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Cash & Equivalents	$57M	$84M	$72M	$103M	$71M	$96M	$128M	$127M	$135M	$177M	$168M	$174M	$160M	$163M	$195M	$189M
Short-term Investments	$103M	$17M	$67M	$50M	$1M	$9M	$25M	$72M	$117M	$134M	$100M	$152M	$189M	$322M	$290M	$324M
Prepaid Expense	$6M	$6M	$6M	$5M	$6M	$4M	$4M	$7M	$8M	$6M	$7M	$7M	$15M	$8M	$10M	$11M
Current Assets	$171M	$112M	$149M	$162M	$83M	$113M	$161M	$210M	$263M	$321M	$280M	$339M	$370M	$500M	$494M	$523M
PP&E (Net)	$25M	$26M	$27M	$30M	$33M	$74M	$77M	$83M	$86M	$82M	$68M	$63M	$64M	$67M	$68M	$69M
PP&E (Gross)	$85M	$83M	$82M	$84M	$86M	$131M	$131M	$136M	$135M	$127M	$116M	$105M	$103M	$98M	$94M	$91M
Accum. Depreciation	$59M	$57M	$55M	$54M	$53M	$57M	$54M	$53M	$49M	$46M	$47M	$43M	$38M	$30M	$26M	$22M
Goodwill	$141M	$141M	$141M	$141M	$141M	$141M	$141M	$141M	$141M	$141M	$141M	$141M	$141M	$141M	$141M	$141M
Intangibles	$59M	$59M	$59M	$59M	$59M	$59M	$59M	$59M	$59M	$59M	$59M	$59M	$59M	$59M	$59M	$59M
Other Non-current Assets	$552.0K	$563.0K	$3M	$3M	$3M	$4M	$5M	$6M	$6M	$7M	$6M	$7M	$5M	$5M	$5M	$5M
Total Assets	$432M	$374M	$417M	$435M	$362M	$445M	$501M	$559M	$619M	$681M	$631M	$707M	$747M	$898M	$971M	$1.05B
Accounts Payable	$1M	$2M	$2M	$2M	$2M	$989.0K	$5M	$3M	$4M	$6M	$10M	$3M	$2M	$4M	$3M	$5M
Current Liabilities	$124M	$86M	$79M	$36M	$33M	$33M	$45M	$47M	$51M	$53M	$67M	$112M	$103M	$115M	$97M	$94M
Capital Leases	$59M	$60M	$64M	$68M	$72M	$78M	$82M	$85M	$89M	$93M	$83M	$100M	$102M	$100M	$103M	$103M
Other Non-current Liabilities	$9M	$10M	$11M	$8M	$8M	$9M	$10M	$7M	$7M	·	·	·	·	·	·	·
Total Liabilities	$277M	$254M	$256M	$240M	$239M	$236M	$251M	$267M	$279M	$306M	$266M	$352M	$319M	$332M	$332M	$346M
Common Stock	$30.0K	$27.0K	$27.0K	$26.0K	$23.0K	$23.0K	$22.0K	$22.0K	$22.0K	$22.0K	$20.0K	$20.0K	$19.0K	$19.0K	$19.0K	$19.0K
Paid-in Capital	$2.11B	$2.02B	$2.01B	$1.99B	$1.87B	$1.86B	$1.86B	$1.85B	$1.84B	$1.82B	$1.62B	$1.61B	$1.57B	$1.55B	$1.54B	$1.52B
Retained Earnings	$-1.96B	$-1.90B	$-1.85B	$-1.79B	$-1.75B	$-1.65B	$-1.60B	$-1.56B	$-1.50B	$-1.45B	$-1.25B	$-1.25B	$-1.14B	$-974M	$-889M	$-817M
AOCI	$-66.0K	$-2.0K	$28.0K	$21.0K	$0	$0	$14.0K	$54.0K	$-19.0K	$-15.0K	$-202.0K	$-865.0K	$-2M	$-6M	$-6M	$-5M
Stockholders' Equity	$155M	$119M	$161M	$195M	$123M	$209M	$251M	$292M	$340M	$375M	$366M	$355M	$428M	$566M	$640M	$702M
Liabilities + Equity	$432M	$374M	$417M	$435M	$362M	$445M	$501M	$559M	$619M	$681M	$631M	$707M	$747M	$898M	$971M	$1.05B
Shares Outstanding	299,306,000	269,817,000	266,732,000	262,264,000	230,510,000	225,463,000	223,923,000	223,108,000	222,209,000	221,286,000	197,064,000	196,880,000	191,409,000	189,885,000	188,430,000	186,632,000

Flusso di cassa 9

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Stock-based Comp	$5M	$6M	$6M	$5M	$7M	$7M	$6M	$11M	$11M	$9M	$9M	$10M	$9M	$10M	$10M	$8M
Operating Cash Flow	$-33M	$-37M	$-33M	$-29M	$-33M	$-49M	$-47M	$-52M	$-59M	$-66M	$-64M	$-59M	$-79M	$-65M	$-71M	$-78M
CapEx	$2M	$288.0K	$873.0K	$41.0K	$-112.0K	$136.0K	$436.0K	$4M	$13M	$16M	$2M	$2M	$2M	$4M	$4M	$8M
Investing Cash Flow	$-88M	$49M	$-16M	$-48M	$8M	$17M	$47M	$42M	$6M	$-77M	$51M	$43M	$63M	$32M	$78M	$13M
Stock Issued	·	·	$17M	$109M	·	·	$0	$-29.0K	·	·	$192.0K	$2M	$236.0K	$897.0K	$2M	$652.0K
Net Stock Activity	·	·	·	·	·	·	·	·	·	·	·	·	$236.0K	·	·	·
Financing Cash Flow	$94M	$-128.0K	$18M	$110M	$561.0K	$982.0K	$643.0K	$2M	$11M	$186M	$187.0K	$30M	$236.0K	$2M	$2M	$652.0K
Net Change in Cash	$-27M	$12M	$-31M	$32M	$-25M	$-31M	$570.0K	$-8M	$-42M	$44M	$-12M	$13M	$-16M	$-31M	$8M	$-65M
Free Cash Flow	·	$-38M	·	·	·	$-49M	·	·	·	$-81M	·	·	$-81M	·	·	$-85M

Redditività 2

Metrica	Tendenza	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
ROA		·	-11.5%	·	-8.5%	-19.1%	-8.8%	·	-10.1%	-7.6%	-15.0%	0.13%	-13.6%	-9.2%	-8.0%	-6.5%	-2.7%
ROE		·	-28.8%	·	-17.3%	-40.6%	-16.9%	·	-18.2%	-14.5%	-26.8%	0.21%	-22.9%	-14.5%	-12.2%	-9.4%	-4.0%

Liquidità e Solvibilità 2

Metrica	Tendenza	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Current Ratio		·	1.3	·	4.6	2.5	3.4	·	4.5	5.2	6.1	4.2	3.0	3.6	4.4	5.1	5.6
Quick Ratio		·	1.2	·	4.3	2.2	3.2	·	4.2	5.0	5.9	4.0	2.9	3.4	4.2	5.0	5.5

Per Azione 4

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Book Value / Share	·	$0.44	·	$0.74	$0.53	$0.93	·	$1.31	$1.53	$1.70	$1.86	$1.80	$2.24	$2.98	$3.39	$3.76
Cash Flow / Share	·	$-0.14	·	·	·	$-0.20	·	·	·	$-0.30	·	·	$-0.41	·	·	·
Cash / Share	·	$0.31	·	$0.39	$0.31	$0.43	·	$0.57	$0.61	$0.80	$0.85	$0.88	$0.84	$0.86	$1.03	$1.01
EPS (TTM)	$-0.94	$-0.92	·	$-0.97	$-1.06	$-0.88	·	$-1.39	$-1.14	$-1.52	$-1.44	$-1.89	$-1.69	$-1.62	$-1.63	$-1.15

Valutazione (TTM) 7

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022
Net Income TTM	$-212M	$-242M	·	$-234M	$-252M	$-209M	·	$-306M	$-245M	$-309M	$-276M	$-362M	$-320M	$-300M	$-298M	$-207M
Market Cap	·	$777M	·	$931M	$629M	$379M	·	$928M	$1.21B	$2.21B	$763M	$1.17B	$626M	$1.14B	$1.21B	$1.54B
P/E	-3.7	-3.1	·	-3.7	-2.6	-1.9	·	-3.0	-4.8	-6.6	-2.7	-3.2	-1.9	-3.7	-3.9	-7.2
P/B	·	6.5	·	4.8	5.1	1.8	·	3.2	3.6	5.9	2.1	3.3	1.5	2.0	1.9	2.2
P / Tangible Book	·	·	·	·	·	40.9	·	10.0	8.7	12.6	4.6	7.6	2.7	3.1	2.8	3.1
P / Cash Flow	·	-20.8	·	·	·	-7.8	·	·	·	-33.7	·	·	-7.9	·	·	-19.8
Earnings Yield	-26.9%	-31.9%	·	-27.3%	-38.8%	-52.4%	·	-33.4%	-20.9%	-15.2%	-37.2%	-31.7%	-51.7%	-27.0%	-25.4%	-13.9%

Periodo più recente a sinistra · valori nulli mostrati come ·

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

16

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Utile netto	$-244M	$-267M	$-283M	$-269M	$-356M
EPS Diluito	$-0.96	$-1.16	$-1.46	$-1.43	$-2.14

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Rapporto corrente	1.9	3.5	3.3	4.0	5.6
Quick Ratio	1.8	3.4	3.2	3.8	5.6

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Flusso di cassa libero	$-145M	$-257M	$-274M	$-311M	$-281M

Proprietari istituzionali (13F) 228 filer · $688.7M totale · Aggiornato al 30 Giugno 2026

17

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Detentori 228

Valore detenuto $688.7M

Nuove posizioni 33

Posizioni chiuse 21

Attività istituzionale — Q2 2026 vs trimestre precedente

Nuove posizioni	Posizioni chiuse	Aumentato	Diminuito	Variazione netta delle azioni
33 (+1 vs trimestre precedente)	21 (-2 vs trimestre precedente)	68 (0 vs trimestre precedente)	66 (+8 vs trimestre precedente)	+20.8M

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione	Valore	Azioni	% di 13F tracciati	Tipo
FMR LLC	$130.629.007	37.429.515	18,97%	Azioni
Flagship Pioneering, LLC	$87.256.477	25.001.856	12,67%	Azioni
RA CAPITAL MANAGEMENT, L.P.	$65.437.500	18.750.000	9,50%	Azioni
BlackRock, Inc.	$58.196.354	16.675.173	8,45%	Azioni
VANGUARD GROUP INC	$42.552.645	10.455.195	6,18%	Azioni
STATE STREET CORP	$39.098.938	11.203.134	5,68%	Azioni
CANADA PENSION PLAN INVESTMENT BOARD	$35.662.216	10.218.400	5,18%	Azioni
VANGUARD CAPITAL MANAGEMENT LLC	$29.230.219	8.375.421	4,24%	Azioni
BANK OF AMERICA CORP /DE/	$20.062.105	5.748.454	2,91%	Azioni
GEODE CAPITAL MANAGEMENT, LLC	$16.329.082	4.677.959	2,37%	Azioni
Marex Group Ltd	$13.921.959	3.989.100	2,02%	Azioni
MARSHALL WACE, LLP	$10.230.711	2.931.436	1,49%	Azioni
Alphabet Inc.	$9.815.625	2.812.500	1,43%	Azioni
GOLDMAN SACHS GROUP INC	$8.264.094	2.367.935	1,20%	Azioni
Integral Health Asset Management, LLC	$6.980.000	2.000.000	1,01%	Azioni
TORONTO DOMINION BANK	$6.883.610	1.972.381	1,00%	Azioni
VANGUARD PORTFOLIO MANAGEMENT LLC	$6.567.095	1.881.689	0,95%	Azioni
JACOBS LEVY EQUITY MANAGEMENT, INC	$6.521.826	1.868.718	0,95%	Azioni
NORTHERN TRUST CORP	$5.598.252	1.604.084	0,81%	Azioni
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$4.813.342	1.379.181	0,70%	Azioni
Woodline Partners LP	$4.599.583	1.317.932	0,67%	Azioni
VANGUARD FIDUCIARY TRUST CO	$4.318.655	1.237.437	0,63%	Azioni
RENAISSANCE TECHNOLOGIES LLC	$4.296.539	1.231.100	0,62%	Azioni
MORGAN STANLEY	$3.977.839	1.139.782	0,58%	Azioni
UBS Group AG	$3.704.429	1.061.441	0,54%	Azioni
AQR CAPITAL MANAGEMENT LLC	$3.361.383	963.147	0,49%	Azioni
Omega Fund Management, LLC	$2.944.688	843.750	0,43%	Azioni
JPMORGAN CHASE & CO	$2.681.678	777.298	0,39%	Azioni
Crestline Management, L.P.	$2.637.619	755.736	0,38%	Azioni
ArrowMark Colorado Holdings LLC	$2.391.086	685.125	0,35%	Azioni
MILLENNIUM MANAGEMENT LLC	$2.280.725	653.503	0,33%	Azioni
DEUTSCHE BANK AG\	$2.251.353	645.087	0,33%	Azioni
TWO SIGMA INVESTMENTS, LP	$2.229.541	638.837	0,32%	Azioni
Corient Private Wealth LP	$2.192.069	628.100	0,32%	Azioni
Point72 Asset Management, L.P.	$2.076.868	595.091	0,30%	Azioni
Invesco Ltd.	$1.759.875	504.262	0,26%	Azioni
Bank of New York Mellon Corp	$1.666.621	477.542	0,24%	Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$1.340.450	384.083	0,19%	Azioni
Nuveen, LLC	$1.290.329	369.722	0,19%	Azioni
Swiss National Bank	$1.214.869	348.100	0,18%	Azioni
BAKER BROS. ADVISORS LP	$1.083.586	310.483	0,16%	Azioni
DIMENSIONAL FUND ADVISORS LP	$1.028.998	294.842	0,15%	Azioni
CITIGROUP INC	$951.109	272.524	0,14%	Azioni
TWO SIGMA ADVISERS, LP	$902.201	221.671	0,13%	Azioni
XTX Topco Ltd	$790.799	226.590	0,11%	Azioni
RHUMBLINE ADVISERS	$779.695	223.412	0,11%	Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$694.510	199.000	0,10%	Opzione Call
Rafferty Asset Management, LLC	$686.591	196.731	0,10%	Azioni
LOS ANGELES CAPITAL MANAGEMENT LLC	$674.557	193.283	0,10%	Azioni
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	$667.313	231.706	0,10%	Azioni

Mostra tutti i 228 proprietari istituzionali →

Insider aziendali 22 insider · 10 dirigenti · 12 direttori

19

Insider	Ruolo	Ultima attività	Azioni possedute	Netto 12m
Steve Harr	President & CEO	07 Marzo 2026 M	7.944.251	$0
Brian Piper	EVP, Chief Financial Officer	17 Febbraio 2026 A	·	$0
Nathan Hardy	EVP, Chief Financial Officer	07 Marzo 2024 A	·	$0
Dhavalkumar Dhirajlal Patel	EVP, Chief Scientific Officer	26 Agosto 2026 M	183.352	$0
Susan D. Wyrick	SVP, Finance and Accounting and Principal Accounting Officer	07 Marzo 2026 M	196.196	$0
Bernard J Cassidy	EVP & General Counsel	07 Marzo 2025 M	112.990	$0
Christian Hordo	EVP, Chief Business Officer	07 Marzo 2024 A	867.455	$0
Douglas E Williams	EVP & President, R&D	07 Marzo 2024 A	·	$0
James J. Macdonald	EVP & General Counsel	13 Giugno 2022 M	497.396	$0
Sunil Agarwal	EVP, Head of Development & CMO	03 Marzo 2022 A	1.550.000	$0
Hans Edgar Bishop	Direttore	06 Luglio 2026 A	5.854.800	$0
Michelle Seitz	Direttore	04 Giugno 2026 A	·	$0
Alise Reicin	Direttore	04 Giugno 2026 A	·	$0
Robert L. Rosiello	Direttore	04 Giugno 2026 A	·	$0
Joshua H. Bilenker	Direttore	04 Giugno 2026 A	20.000	$0
Richard Mulligan	Direttore	04 Giugno 2026 A	2.698.121	$0
Patrick Y Yang	Direttore	04 Giugno 2026 A	149.250	$0
Robert Nelsen	Direttore	04 Giugno 2026 A	12.446.022	$0
Mary Agnes Wilderotter	Direttore	05 Giugno 2025 A	7.106	$0
Douglas G. Cole	Direttore	06 Giugno 2024 A	·	$0
Geoffrey Von Maltzahn	Direttore	03 Febbraio 2021 A	366.122	$0
FMR LLC	Proprietario del 10%	08 Gennaio 2025 S	4.541.511	$0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Proprietà ETF Posseduti da 26 ETF

20

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo	Peso	Unità	Aggiornato al	Fonte
BBC · ETFis Series Trust I	0,78%	115.976 NS	31 Luglio 2026	N-PORT
LABU · Direxion Shares ETF Trust	0,15%	240.493 NS	31 Luglio 2026	N-PORT
IBBQ · Invesco Exchange-Traded Fund Trust …	0,06%	21.172 SH	01 Ottobre 2026	Giornaliero
PWS · Pacer Funds Trust	0,04%	3.286 NS	31 Luglio 2026	N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust	0,04%	392.413 SH	01 Ottobre 2026	Giornaliero
IBB · iShares Trust	0,04%	1.388.372 SH	11 Settembre 2026	Giornaliero
VTWG · VANGUARD SCOTTSDALE FUNDS	0,04%	196.803 SH	19 Agosto 2026	Giornaliero
IWO · iShares Trust	0,04%	1.718.279 SH	11 Settembre 2026	Giornaliero
VTWO · VANGUARD SCOTTSDALE FUNDS	0,02%	1.056.163 SH	19 Agosto 2026	Giornaliero
IWM · iShares Trust	0,02%	4.720.089 SH	11 Settembre 2026	Giornaliero
RSSL · Global X Funds	0,02%	87.720 NS	31 Luglio 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0,01%	1.941.879 SH	19 Agosto 2026	Giornaliero
VHT · VANGUARD WORLD FUND	0,01%	521.984 SH	19 Agosto 2026	Giornaliero
ISCG · iShares Trust	0,01%	28.058 SH	11 Settembre 2026	Giornaliero
FHLC · FIDELITY COVINGTON TRUST	0,01%	80.330 NS	31 Luglio 2026	N-PORT
WSML · iShares Trust	0,00%	10.383 SH	11 Settembre 2026	Giornaliero
TILT · FlexShares Trust	0,00%	22.436 NS	31 Luglio 2026	N-PORT
DFAS · Dimensional ETF Trust	0,00%	110.952 NS	31 Luglio 2026	N-PORT
ITOT · iShares Trust	0,00%	256.132 SH	11 Settembre 2026	Giornaliero
IWV · iShares Trust	0,00%	50.195 SH	09 Settembre 2026	Giornaliero
DFAU · Dimensional ETF Trust	0,00%	12.291 NS	31 Luglio 2026	N-PORT
VTI · VANGUARD INDEX FUNDS	0,00%	6.251.644 SH	19 Agosto 2026	Giornaliero
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	13.302 SH	19 Agosto 2026	Giornaliero
ISCB · iShares Trust	·	8.018 SH	11 Settembre 2026	Giornaliero
ISCV · iShares Trust	·	21.821 SH	11 Settembre 2026	Giornaliero
SMLF · iShares Trust	·	429.504 SH	11 Settembre 2026	Giornaliero

SANA Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

21

rating · 15 analisti COMPRA

Target mediano $7.00 +142,2%

6 40,0% Acquisto forte

7 46,7% Compra

2 13,3% Mantieni

0 0,0% Vendi

0 0,0% Vendita forte

Target Price a 12 Mesi

7 analisti · 2026-09-30

Target medio $8.43 +191,6%

← Sotto tutti i target Prezzo attuale $2.89

Basso$6.00 Media$8.43 Alto$12.00

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

22

Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.

Ticker	Capitalizzazione di Mercato	P/E	Rev YoY	Margine Netto	ROE	Margine lordo
SANA	$1.09B	-4.2	·	·	-172.3%	·
CRVS	$575M	-14.5	·	·	-21.6%	·
JBIO	$761M	-4.8	·	·	-47.7%	·
GLUE	$1.03B	·	63.5%	-31.2%	-15.4%	·
RIGL	$784M	2.2	64.1%	124.7%	155.1%	·
OBX	·	·	·	·	·	·
ARDX	$1.42B	-22.4	22.1%	-15.1%	-40.2%	·
AVTX	$336M	-3.1	-86.6%	-132642.4%	-83.4%	·
ANNX	$750M	-3.7	·	·	-100.7%	·

Ultime notizie Notizie recenti che menzionano questa società

23

Iraq Revive Syria Land Route, Post-Assad, To Export Oil To Europe ZeroHedge · 5 mesi, 4 settimane fa

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

26

Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

SANA Sana Biotechnology, Inc. - Common Stock